UnitedHealth Group - UNH Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $599.39
  • Forecasted Upside: 26.41%
  • Number of Analysts: 15
  • Breakdown:
  • 0 Sell Ratings
  • 3 Hold Ratings
  • 12 Buy Ratings
  • 0 Strong Buy Ratings
▼ -1.07 (-0.23%)

This chart shows the closing price for UNH by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New UnitedHealth Group Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for UNH and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for UNH

Analyst Price Target is $599.39
▲ +26.41% Upside Potential
This price target is based on 15 analysts offering 12 month price targets for UnitedHealth Group in the last 3 months. The average price target is $599.39, with a high forecast of $650.00 and a low forecast of $550.00. The average price target represents a 26.41% upside from the last price of $474.17.

This chart shows the closing price for UNH for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 15 contributing investment analysts is to buy stock in UnitedHealth Group. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 18 buy ratings
  • 3 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 19 buy ratings
  • 1 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 20 buy ratings
  • 2 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 19 buy ratings
  • 2 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 17 buy ratings
  • 3 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 15 buy ratings
  • 3 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 13 buy ratings
  • 3 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 12 buy ratings
  • 3 hold ratings
  • 0 sell ratings

Latest Recommendations

  • 0 strong buy ratings
  • 12 buy ratings
  • 3 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/24/2023Deutsche Bank AktiengesellschaftBoost TargetBuy$615.00 ➝ $617.00Low
1/18/2023UBS GroupLower TargetNeutral$590.00 ➝ $550.00Low
1/17/2023Loop CapitalBoost Target$575.00 ➝ $590.00Low
12/7/2022Credit Suisse GroupBoost TargetOutperform$590.00 ➝ $610.00Low
11/23/2022Morgan StanleyReiterated RatingOverweight$587.00Low
11/21/2022Raymond JamesDowngradeStrong-Buy ➝ Outperform$615.00Low
10/19/2022Raymond JamesLower TargetStrong-Buy$635.00 ➝ $615.00Low
10/18/2022Deutsche Bank AktiengesellschaftBoost TargetBuy$569.00 ➝ $615.00Low
10/17/2022Royal Bank of CanadaBoost TargetOutperform$588.00 ➝ $592.00Low
10/17/2022SVB LeerinkLower TargetOutperform$625.00 ➝ $618.00Low
10/17/2022Credit Suisse GroupBoost TargetOutperform$579.00 ➝ $590.00Low
9/22/2022Raymond JamesBoost TargetStrong-Buy$620.00 ➝ $635.00Low
9/8/2022Deutsche Bank AktiengesellschaftBoost TargetBuy$556.00 ➝ $569.00Low
8/10/2022MizuhoBoost TargetBuy$550.00 ➝ $600.00Low
7/25/2022ArgusBoost TargetBuy$580.00 ➝ $650.00Low
7/21/2022UBS GroupBoost TargetNeutral ➝ Neutral$545.00 ➝ $570.00Low
7/20/2022BMO Capital MarketsBoost Target$600.00 ➝ $610.00Low
7/19/2022Deutsche Bank AktiengesellschaftBoost Target$549.00 ➝ $556.00Low
7/18/2022SVB LeerinkBoost TargetOutperform$600.00 ➝ $625.00Low
7/18/2022OppenheimerBoost TargetOutperform$600.00 ➝ $610.00Low
7/18/2022Credit Suisse GroupBoost TargetOutperform$575.00 ➝ $579.00Low
7/18/2022Morgan StanleyBoost Target$570.00 ➝ $587.00Low
7/14/2022Morgan StanleyLower TargetOverweight$577.00 ➝ $570.00Low
6/16/2022Loop CapitalInitiated CoverageBuy$575.00High
5/26/2022Sanford C. BernsteinDowngradeOutperform ➝ Market Perform$561.00Medium
5/25/2022Wells Fargo & CompanyLower TargetOverweight$613.00 ➝ $612.00Low
4/22/2022Wells Fargo & CompanyBoost TargetOverweight$565.00 ➝ $613.00High
4/19/2022SVB LeerinkBoost TargetOutperform$550.00 ➝ $600.00Low
4/19/2022Raymond JamesBoost TargetStrong-Buy$540.00 ➝ $620.00Low
4/19/2022BMO Capital MarketsBoost TargetMarket Perform$510.00 ➝ $600.00Low
4/18/2022CowenBoost Target$512.00 ➝ $596.00Low
4/18/2022Morgan StanleyBoost TargetOverweight$570.00 ➝ $577.00Low
4/18/2022CowenBoost Target$512.00 ➝ $596.00Low
4/18/2022Royal Bank of CanadaSet TargetOutperform$563.00Low
4/18/2022Deutsche Bank AktiengesellschaftBoost TargetBuy$482.00 ➝ $549.00Low
4/18/2022Credit Suisse GroupBoost TargetOutperform$564.00 ➝ $595.00Low
4/18/2022OppenheimerBoost TargetOutperform$550.00 ➝ $600.00Low
4/14/2022Royal Bank of CanadaBoost TargetOutperform$563.00 ➝ $588.00Low
4/7/2022Truist FinancialBoost Target$575.00 ➝ $610.00Medium
3/30/2022BarclaysBoost TargetOverweight$495.00 ➝ $565.00High
1/26/2022SVB LeerinkBoost TargetOutperform$480.00 ➝ $550.00Low
1/21/2022BMO Capital MarketsBoost TargetMarket Perform$500.00 ➝ $510.00Low
1/21/2022Raymond JamesBoost TargetStrong-Buy$515.00 ➝ $540.00Low
1/20/2022Deutsche Bank AktiengesellschaftBoost TargetBuy$477.00 ➝ $482.00Low
1/11/2022Sanford C. BernsteinBoost Target$508.00 ➝ $564.00Low
1/10/2022Edward JonesInitiated CoverageBuyLow
1/5/2022Truist FinancialBoost TargetBuy$520.00 ➝ $575.00High
12/20/2021MizuhoBoost TargetBuy$500.00 ➝ $550.00Low
12/14/2021The Goldman Sachs GroupInitiated CoverageBuy$535.00Low
12/2/2021BMO Capital MarketsBoost TargetNeutral ➝ Market Perform$475.00 ➝ $500.00Low
12/1/2021Truist FinancialBoost TargetBuy$500.00 ➝ $520.00Medium
12/1/2021Royal Bank of CanadaBoost TargetOutperform$476.00 ➝ $512.00Low
12/1/2021UBS GroupBoost TargetNeutral$435.00 ➝ $452.00Low
12/1/2021Morgan StanleyBoost TargetOverweight$499.00 ➝ $526.00Medium
11/16/2021Deutsche Bank AktiengesellschaftBoost TargetBuy$421.00 ➝ $477.00Low
11/10/2021MizuhoBoost TargetBuy$455.00 ➝ $500.00Medium
10/25/2021Wells Fargo & CompanyBoost TargetOverweight$478.00 ➝ $520.00Low
10/18/2021BMO Capital MarketsBoost TargetMarket Perform$435.00 ➝ $475.00Low
10/15/2021Evercore ISIBoost TargetOutperform$360.00 ➝ $480.00Low
10/15/2021Morgan StanleyBoost TargetOverweight$488.00 ➝ $499.00Low
10/15/2021Royal Bank of CanadaBoost TargetOutperform$473.00 ➝ $476.00High
10/15/2021Credit Suisse GroupBoost TargetOutperform$462.00 ➝ $495.00High
10/15/2021OppenheimerBoost TargetOutperform$465.00 ➝ $475.00High
9/27/2021SVB LeerinkInitiated CoverageOutperform$480.00Medium
9/9/2021CowenInitiated CoverageOutperform$478.00High
8/31/2021Morgan StanleyLower TargetOverweight$515.00 ➝ $488.00Medium
7/16/2021StephensBoost TargetOverweight ➝ Overweight$440.00 ➝ $460.00Low
7/16/2021Truist FinancialBoost TargetBuy$480.00 ➝ $500.00Low
7/16/2021Raymond JamesBoost TargetStrong-Buy$435.00 ➝ $515.00Low
7/16/2021Credit Suisse GroupBoost TargetOutperform$430.00 ➝ $462.00Low
7/16/2021CitigroupBoost TargetBuy$450.00 ➝ $480.00Low
7/16/2021BarclaysBoost TargetOverweight$435.00 ➝ $465.00Low
7/15/2021OppenheimerReiterated RatingBuy$440.00High
7/13/2021Deutsche Bank AktiengesellschaftBoost TargetBuy$418.00 ➝ $421.00Medium
7/9/2021Seaport Res PtnReiterated RatingBuyMedium
6/1/2021Bank of AmericaBoost TargetBuy$450.00 ➝ $522.00High
5/24/2021Wells Fargo & CompanyInitiated CoverageOverweight$478.00N/A
5/18/2021Wells Fargo & CompanyInitiated CoverageOverweight$478.00Low
5/7/2021MizuhoBoost TargetBuy$394.00 ➝ $455.00Low
4/21/2021ArgusUpgradeHold ➝ Buy$450.00Low
4/16/2021StephensBoost TargetOverweight$415.00 ➝ $425.00Medium
4/16/2021Credit Suisse GroupBoost TargetOutperform$415.00 ➝ $430.00Low
4/16/2021Morgan StanleyBoost TargetOverweight$462.00 ➝ $515.00Low
4/16/2021BMO Capital MarketsBoost TargetMarket Perform$410.00 ➝ $435.00Low
4/16/2021OppenheimerBoost TargetOutperform$375.00 ➝ $440.00Low
4/16/2021Deutsche Bank AktiengesellschaftBoost TargetBuy$409.00 ➝ $418.00Low
4/16/2021BarclaysBoost TargetOverweight$405.00 ➝ $435.00Low
4/14/2021Truist FinancialBoost TargetBuy$420.00 ➝ $450.00Low
4/9/2021MizuhoBoost TargetBuy$380.00 ➝ $394.00Medium
1/21/2021Deutsche Bank AktiengesellschaftBoost TargetBuy$404.00 ➝ $409.00Medium
1/21/2021Bank of AmericaReiterated RatingBuy$415.00Medium
1/17/2021BarclaysReiterated RatingBuy$405.00Low
1/7/2021Deutsche Bank AktiengesellschaftBoost TargetBuy$359.00 ➝ $404.00N/A
1/5/2021Truist FinancialBoost Target$400.00 ➝ $420.00N/A
12/14/2020SVB LeerinkBoost TargetOutperform$378.00 ➝ $390.00Medium
12/3/2020Deutsche Bank AktiengesellschaftBoost Target$332.00 ➝ $359.00Low
12/2/2020Truist FinancialBoost Target$380.00 ➝ $400.00Low
12/2/2020BMO Capital MarketsBoost TargetNeutral ➝ Market Perform$385.00 ➝ $395.00Low
12/2/2020JPMorgan Chase & Co.Boost Target$360.00 ➝ $430.00Low
12/2/2020Raymond JamesBoost TargetStrong-Buy$355.00 ➝ $405.00Low
12/2/2020Morgan StanleyBoost TargetOverweight$371.00 ➝ $454.00Low
12/2/2020SVB LeerinkBoost TargetOutperform$373.00 ➝ $378.00Medium
12/2/2020Cantor FitzgeraldBoost TargetOverweight$360.00 ➝ $375.00Medium
12/2/2020StephensBoost TargetOverweight$355.00 ➝ $380.00Medium
11/11/2020Piper SandlerBoost TargetOverweight$385.00 ➝ $409.00Low
11/9/2020MizuhoBoost TargetBuy$361.00 ➝ $380.00High
11/5/2020Credit Suisse GroupBoost TargetBuy ➝ Average$355.00 ➝ $395.00Low
10/19/2020ArgusDowngradeBuy ➝ HoldLow
10/16/2020UBS GroupBoost TargetNeutral$319.00 ➝ $330.00Low
10/15/2020Jefferies Financial GroupBoost TargetHold$310.00 ➝ $335.00Medium
10/15/2020Royal Bank of CanadaBoost TargetOutperform$384.00 ➝ $389.00Medium
10/15/2020OppenheimerBoost TargetOutperform$353.00 ➝ $375.00Medium
10/15/2020Raymond JamesBoost TargetStrong-Buy$350.00 ➝ $355.00Medium
10/15/2020SVB LeerinkBoost TargetOutperform$370.00 ➝ $373.00Medium
10/15/2020Piper SandlerBoost TargetOverweight$350.00 ➝ $385.00Medium
10/14/2020Royal Bank of CanadaReiterated RatingBuyLow
10/14/2020Credit Suisse GroupSet TargetBuy$335.00Low
10/13/2020BarclaysBoost TargetOverweight$322.00 ➝ $365.00Low
8/28/2020Bank of AmericaBoost TargetBuy$351.00 ➝ $365.00Low
7/16/2020Royal Bank of CanadaBoost Target$341.00 ➝ $384.00Low
7/16/2020Morgan StanleyReiterated RatingBuy$371.00Low
7/16/2020OppenheimerBoost TargetOutperform$343.00 ➝ $353.00Low
7/16/2020Deutsche Bank AktiengesellschaftBoost TargetBuy$293.00 ➝ $312.00Low
7/16/2020SVB LeerinkBoost TargetOutperform$360.00 ➝ $370.00Low
7/16/2020Raymond JamesBoost TargetStrong-Buy$325.00 ➝ $350.00Low
7/16/2020Credit Suisse GroupBoost TargetOutperform$325.00 ➝ $335.00Medium
7/16/2020StephensBoost TargetOverweight$325.00 ➝ $335.00Medium
7/16/2020CitigroupBoost TargetBuy$339.00 ➝ $357.00Medium
7/16/2020Piper SandlerBoost TargetOverweight$339.00 ➝ $350.00Medium
7/15/2020MizuhoReiterated RatingBuy$315.00Low
7/10/2020Jefferies Financial GroupBoost TargetHold$283.00 ➝ $295.00Low
7/9/2020Royal Bank of CanadaReiterated RatingBuy$341.00Medium
7/1/2020SVB LeerinkInitiated CoverageOutperform$360.00Medium
6/5/2020The Goldman Sachs GroupInitiated CoverageBuy$384.00High
6/2/2020StephensBoost TargetOverweight$310.00 ➝ $325.00Low
5/27/2020Credit Suisse GroupReiterated RatingBuyMedium
5/21/2020SunTrust BanksBoost TargetBuy$340.00 ➝ $360.00Low
4/30/2020Morgan StanleyBoost TargetOverweight$289.00 ➝ $371.00High
4/24/2020CitigroupLower TargetBuy$346.00 ➝ $339.00Low
4/16/2020Raymond JamesLower Target$340.00 ➝ $325.00High
4/16/2020Deutsche Bank AktiengesellschaftLower TargetBuy$308.00 ➝ $293.00High
4/16/2020Credit Suisse GroupLower TargetOutperform$330.00 ➝ $325.00High
4/16/2020CowenBoost TargetPositive ➝ Outperform$320.00 ➝ $340.00High
4/15/2020StephensBoost TargetOverweight$300.00 ➝ $310.00Low
4/13/2020SunTrust BanksLower TargetBuy$360.00 ➝ $340.00Low
3/29/2020BarclaysReiterated RatingBuy$322.00High
3/27/2020Morgan StanleyLower TargetOverweight$341.00 ➝ $281.00Low
3/20/2020Deutsche Bank AktiengesellschaftUpgradeHold ➝ Buy$308.00High
3/4/2020CitigroupReiterated RatingBuyMedium
2/18/2020Deutsche Bank AktiengesellschaftBoost TargetHold$297.00 ➝ $362.00Medium
1/19/2020BarclaysReiterated RatingBuyLow
1/16/2020OppenheimerBoost TargetOutperform$312.00 ➝ $343.00Low
1/16/2020UBS GroupBoost TargetNeutral$279.00 ➝ $304.00Low
1/16/2020Cantor FitzgeraldBoost TargetOverweight$315.00 ➝ $330.00Low
1/16/2020CitigroupBoost TargetBuy$286.00 ➝ $346.00Low
1/15/2020StephensBoost TargetOverweight ➝ Overweight$325.00 ➝ $333.00Low
1/8/2020Credit Suisse GroupBoost TargetOutperform$320.00 ➝ $330.00High
12/20/2019JPMorgan Chase & Co.Boost TargetOverweight$276.00 ➝ $361.00Medium
12/19/2019ArgusReiterated RatingPositive ➝ Buy$340.00Low
12/18/2019SunTrust BanksBoost TargetBuy$335.00 ➝ $350.00Low
12/11/2019Wells Fargo & CompanyReiterated RatingOverweight$318.00 ➝ $335.00Low
12/10/2019Evercore ISIInitiated CoverageBuy$285.00Medium
12/5/2019Raymond JamesBoost TargetBuy$300.00 ➝ $320.00Low
12/4/2019UBS GroupBoost TargetNeutral$257.00 ➝ $279.00Low
12/4/2019BMO Capital MarketsReiterated RatingMarket Perform$310.00Medium
12/4/2019Cantor FitzgeraldBoost TargetBuy$310.00 ➝ $315.00Medium
12/4/2019Piper Jaffray CompaniesBoost TargetOverweight$312.00 ➝ $325.00Medium
12/4/2019Credit Suisse GroupBoost TargetOutperform$293.00 ➝ $320.00Medium
12/4/2019Wells Fargo & CompanyBoost TargetOutperform ➝ In-Line$288.00 ➝ $318.00Medium
12/2/2019BarclaysBoost TargetOverweight$260.00 ➝ $305.00Low
11/26/2019MizuhoReiterated RatingBuy$270.00 ➝ $300.00Low
11/22/2019Morgan StanleyReiterated RatingBuy$294.00 ➝ $312.00Low
11/18/2019SunTrust BanksReiterated RatingBuy$310.00 ➝ $335.00Low
10/17/2019MizuhoInitiated CoverageBuy$270.00Low
10/17/2019UBS GroupLower TargetNeutral$281.00 ➝ $257.00Medium
10/16/2019CitigroupLower TargetBuy$299.00 ➝ $286.00Low
10/15/2019Cantor FitzgeraldSet TargetBuy$310.00Low
10/10/2019Jefferies Financial GroupDowngradeBuy ➝ Hold$300.00 ➝ $235.00High
10/8/2019Cantor FitzgeraldSet TargetBuy$310.00Low
10/8/2019BarclaysSet TargetBuy$260.00Low
9/30/2019BMO Capital MarketsDowngradeOutperform ➝ Market Perform$292.00 ➝ $249.00Medium
9/26/2019Morgan StanleyLower TargetOverweight$298.00 ➝ $294.00Medium
9/12/2019Deutsche Bank AktiengesellschaftInitiated CoverageHold$263.00High
8/29/2019Credit Suisse GroupSet TargetBuy$293.00Low
7/19/2019Royal Bank of CanadaSet TargetBuy$311.00Medium
7/19/2019OppenheimerSet TargetBuy$312.00Medium
7/19/2019Cantor FitzgeraldSet TargetBuy$310.00N/A
7/19/2019Raymond JamesBoost TargetBuy$265.00 ➝ $300.00Low
7/12/2019Morgan StanleyBoost TargetOverweight$285.00 ➝ $298.00Low
5/10/2019CitigroupUpgradeNeutral ➝ Buy$247.00 ➝ $280.00Low
4/23/2019UBS GroupInitiated CoverageNeutral ➝ Neutral$238.00Low
4/17/2019CitigroupLower TargetNeutral ➝ Neutral$288.00 ➝ $247.00Medium
4/17/2019BarclaysLower TargetOverweight ➝ Overweight$290.00 ➝ $270.00Medium
4/17/2019Bank of AmericaReiterated RatingBuy ➝ Buy$320.00 ➝ $290.00Medium
4/17/2019Morgan StanleyLower TargetOverweight ➝ Overweight$315.00 ➝ $285.00Medium
4/17/2019Raymond JamesLower TargetStrong-Buy ➝ Strong-Buy$310.00 ➝ $265.00Medium
4/17/2019SunTrust BanksLower TargetBuy$300.00High
2/8/2019Credit Suisse GroupReiterated RatingBuy$310.00Low
1/16/2019OppenheimerBoost TargetOutperform$300.00 ➝ $305.00Low
1/15/2019Cantor FitzgeraldReiterated RatingBuy$310.00High
1/14/2019StephensInitiated CoverageOverweight$287.00Medium
12/17/2018ArgusBoost TargetBuy ➝ Buy$285.00 ➝ $295.00Low
11/28/2018Raymond JamesSet TargetBuy$310.00Low
11/28/2018OppenheimerBoost TargetOutperform$295.00 ➝ $300.00Low
11/28/2018Piper Jaffray CompaniesBoost TargetOverweight$312.00High
11/27/2018BMO Capital MarketsSet TargetBuy$310.00Low
11/21/2018Cantor FitzgeraldReiterated RatingBuy$310.00Medium
10/18/2018BMO Capital MarketsBoost TargetOutperform$310.00Low
10/18/2018ArgusBoost TargetPositive ➝ Buy$285.00Low
10/17/2018OppenheimerBoost TargetOutperform$276.00 ➝ $295.00Low
10/17/2018Royal Bank of CanadaBoost TargetOutperform$308.00Low
10/17/2018Piper Jaffray CompaniesBoost TargetOverweight$300.00Low
10/17/2018Raymond JamesBoost TargetStrong-Buy ➝ Strong-Buy$304.00 ➝ $310.00Low
10/17/2018Bank of AmericaBoost TargetBuy ➝ Buy$315.00 ➝ $320.00Medium
10/12/2018BarclaysBoost TargetOverweight$265.00 ➝ $280.00Low
10/3/2018Jefferies Financial GroupBoost TargetBuy ➝ Buy$270.00 ➝ $311.00Low
9/24/2018Raymond JamesBoost TargetStrong-Buy ➝ Strong-Buy$285.00 ➝ $304.00Low
9/17/2018CowenInitiated CoverageOutperform$308.00Low
9/10/2018CitigroupDowngradeBuy ➝ Neutral$288.00High
9/5/2018Morgan StanleyBoost TargetOverweight ➝ Overweight$278.00 ➝ $305.00Low
8/9/2018Cantor FitzgeraldReiterated RatingBuy$300.00Low
7/18/2018SVB LeerinkReiterated RatingOutperformLow
7/18/2018Morgan StanleyBoost TargetOverweight ➝ $255.42$277.00 ➝ $278.00Low
7/18/2018CitigroupBoost TargetBuy ➝ $255.42$275.00 ➝ $288.00Medium
7/18/2018Royal Bank of CanadaBoost TargetOutperform ➝ $255.42$282.00 ➝ $284.00Medium
7/17/2018The Goldman Sachs GroupReiterated RatingBuy$277.00Low
7/5/2018Cantor FitzgeraldReiterated RatingBuy$300.00Medium
6/21/2018BMO Capital MarketsBoost TargetOutperform ➝ Positive$285.00 ➝ $300.00Low
6/11/2018SunTrust BanksInitiated CoverageBuy$300.00Medium
6/7/2018BMO Capital MarketsBoost TargetOutperform ➝ Buy$275.00 ➝ $285.00Low
4/18/2018Piper Jaffray CompaniesReiterated RatingBuy$270.00Low
4/18/2018Credit Suisse GroupBoost TargetOutperform ➝ Outperform$260.00 ➝ $270.00Low
4/18/2018OppenheimerBoost TargetOutperform$260.00 ➝ $276.00Low
4/18/2018Cantor FitzgeraldBoost TargetOverweight$300.00Low
4/18/2018Royal Bank of CanadaReiterated RatingBuyLow
4/18/2018Sanford C. BernsteinSet TargetBuy$259.00 ➝ $275.00Low
4/18/2018Morgan StanleyBoost TargetOverweight ➝ Overweight$275.00 ➝ $277.00Low
4/18/2018JPMorgan Chase & Co.Boost TargetOverweight$266.00Low
3/9/2018Credit Suisse GroupReiterated RatingBuyLow
3/8/2018Cantor FitzgeraldReiterated RatingBuy$280.00Medium
3/8/2018BarclaysInitiated CoverageOverweight ➝ Overweight$265.00Medium
(Data available from 2/7/2018 forward)

News Sentiment Rating

0.45 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 13 very positive mentions
  • 26 positive mentions
  • 4 negative mentions
  • 3 very negative mentions
  • 34 very positive mentions
  • 62 positive mentions
  • 12 negative mentions
  • 3 very negative mentions
  • 17 very positive mentions
  • 25 positive mentions
  • 5 negative mentions
  • 2 very negative mentions
  • 12 very positive mentions
  • 39 positive mentions
  • 8 negative mentions
  • 7 very negative mentions
  • 30 very positive mentions
  • 59 positive mentions
  • 8 negative mentions
  • 5 very negative mentions
  • 17 very positive mentions
  • 36 positive mentions
  • 7 negative mentions
  • 1 very negative mentions
  • 17 very positive mentions
  • 20 positive mentions
  • 2 negative mentions
  • 2 very negative mentions
  • 25 very positive mentions
  • 58 positive mentions
  • 5 negative mentions
  • 4 very negative mentions

Current Sentiment

  • 25 very positive mentions
  • 58 positive mentions
  • 5 negative mentions
  • 4 very negative mentions

Recent Stories by Sentiment

UnitedHealth Group logo
UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Minnetonka, MN.
Read More

Today's Range

Now: $474.17
Low: $469.98
High: $474.82

50 Day Range

MA: $511.34
Low: $470.83
High: $547.92

52 Week Range

Now: $474.17
Low: $445.73
High: $558.10


1,429,567 shs

Average Volume

4,266,935 shs

Market Capitalization

$443.04 billion

P/E Ratio


Dividend Yield




Frequently Asked Questions

What sell-side analysts currently cover shares of UnitedHealth Group?

The following Wall Street research analysts have issued research reports on UnitedHealth Group in the last twelve months: Argus, Barclays PLC, BMO Capital Markets, Cowen Inc, Cowen Inc., Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, Loop Capital, Mizuho, Morgan Stanley, Oppenheimer Holdings Inc., Raymond James, Royal Bank of Canada, Sanford C. Bernstein, StockNews.com, SVB Leerink LLC, Truist Financial Co., UBS Group AG, and Wells Fargo & Company.
View the latest analyst ratings for UNH.

What is the current price target for UnitedHealth Group?

18 Wall Street analysts have set twelve-month price targets for UnitedHealth Group in the last year. Their average twelve-month price target is $599.39, suggesting a possible upside of 26.1%. Argus has the highest price target set, predicting UNH will reach $650.00 in the next twelve months. UBS Group AG has the lowest price target set, forecasting a price of $550.00 for UnitedHealth Group in the next year.
View the latest price targets for UNH.

What is the current consensus analyst rating for UnitedHealth Group?

UnitedHealth Group currently has 3 hold ratings and 12 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe UNH will outperform the market and that investors should add to their positions of UnitedHealth Group.
View the latest ratings for UNH.

What other companies compete with UnitedHealth Group?

How do I contact UnitedHealth Group's investor relations team?

UnitedHealth Group's physical mailing address is 9900 BREN ROAD EAST, MINNETONKA MN, 55343. The healthcare conglomerate's listed phone number is (952) 936-1300 and its investor relations email address is [email protected] The official website for UnitedHealth Group is www.unitedhealthgroup.com. Learn More about contacing UnitedHealth Group investor relations.